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Introduction
============

Coronavirus disease 2019 (COVID-19) originated in the Huanan South China Seafood Market in Wuhan. It has posed a global health threat. COVID-19 can present with a spectrum of clinical manifestations including fever, myalgia, cough, dyspnea, and less frequently headache, diarrhea, nausea, and vomiting. Although respiratory symptoms predominate, multiple organ dysfunction may also occur with COVID-19. Coagulopathy has been found as a prominent feature of COVID-19 and severe coagulation dysfunction may be associated with poor prognosis \[[@REF1]-[@REF3]\]. Neurological and cardiovascular complications are also common in COVID-19 patients. No effective treatment has yet been established.

Case presentation
=================

The mean age was 59.6 years (range 47-71 years) and 2/3 were female. Two were Hispanic and one was Pilipino. Comorbidities included hypertension and diabetes mellitus. COVID-19 was diagnosed by nasopharyngeal swab reverse-transcription polymerase chain reaction (RT-PCR) and influenza by rapid antigen assay. Two patients had influenza type B and one had influenza type A. The presenting sign and symptoms were cough, fever, shortness of breath and myalgia. Chest X-ray (CXR) and computed tomography (CT) of the case 1 and case 2 are shown in Figure [1A](#FIG1){ref-type="fig"}-[1D](#FIG1){ref-type="fig"}.

![(A) CXR of case 1 showing bilateral patchy infiltrates. (B) CT chest of case 1 showing diffuse scattered areas of ground-glass and mixed attenuating opacities. (C) CXR of case 2 showing multi-lobar infiltrates. (D) CT chest of case 2 showing diffuse bilateral ground-glass infiltrates.\
CXR: Chest X-ray](cureus-0012-00000009852-i01){#FIG1}

CXR of the case 3 is shown in Figure [2](#FIG2){ref-type="fig"}.

![CXR of case 3 showing bilateral patchy infiltrates.\
CXR: Chest X-ray](cureus-0012-00000009852-i02){#FIG2}

One patient (case 2) had positive blood culture for Enterococcus faecium. Two patients required intubation during their hospital course. Inflammatory markers (ESR, CRP, IL-6) were elevated in the patients. All three patients were treated with hydroxychloroquine, azithromycin, ceftriaxone for COVID-19 and Oseltamivir for influenza. All were discharged in stable condition. Table [1](#TAB1){ref-type="table"} summarizes the clinical characteristics of the three patients.

###### Summarizes the clinical characteristics and outcome of the three patients.

Reference ranges are as follows: white blood cells 4.5-11 K/mm^3^, hemoglobin 12-16 g/dl, platelets 140-440 K/mm^3^, creatine kinase 30-223 unit/L, troponin less than 0.03 ng/ml, sodium 135-145 meq/L, potassium 3.5-5 meq/L, chloride 98-107 meq/L, HCO3 21-31 meq/L, BUN 7-23 mg/dl, creatinine 0.6-1.30 mg/dl, aspartate transaminase 13-39 U/L, alanine transaminase 7-52 U/L, ESR 0-32 mm/hr, CRP less than 10 mg/L, IL-6 0-15.5 pg/ml, fibrinogen 183-503 mg/dl, ferritin 12-300 ng/ml.

DM: diabetes mellitus; HTN: hypertension; SOB: shortness of breath; RT-PCR: reverse-transcription polymerase chain reaction; ND: not done; HCO3: bicarbonate; BUN: blood urea nitrogen; CK: creatine kinase; AST: aspartate transaminase; ALT: alanine transaminase; ESR: erythrocyte sedimentation rate; CRP: c-reactive protein; IL-6: Interleukin-6.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------- ----------------------------------------------
  Variables                                                                                                                                                               Case 1                                                                    Case 2                                                                           Case 3
  Age                                                                                                                                                                     47                                                                        71                                                                               61
  Sex                                                                                                                                                                     Male                                                                      Female                                                                           Female
  Race                                                                                                                                                                    Pilipino                                                                  Hispanic                                                                         Hispanic
  Medical history                                                                                                                                                         DM                                                                        None                                                                             DM, HTN
  Smoking history                                                                                                                                                         Unknown                                                                   Negative                                                                         Former
  Presenting complaints                                                                                                                                                   Cough, fever                                                              Fever, cough, SOB                                                                SOB, myalgia
  Vital signs on presentation: Blood pressure mm Hg / heart rate per minute / temperature degree Celsius / respiratory rate per minute / saturation percent on room air   109-65/88/38/18/98%                                                       196-97/105/35.8 24/83%                                                           175-106/131 37.1/18/94
  COVID-19 diagnostic test                                                                                                                                                RT-PCR                                                                    RT-PCR                                                                           RT-PCR
  Influenza diagnostic test / type                                                                                                                                        Antigen detection assay/ B                                                Antigen detection assay/ B                                                       Antigen detection assay/ A
  Chest X-ray                                                                                                                                                             Bilateral patchy infiltrates                                              Multi-lobar infiltrates                                                          Bilateral patchy infiltrates
  Chest computed tomography                                                                                                                                               Diffuse scattered areas of ground-glass and mixed attenuating opacities   Diffuse bilateral ground-glass infiltrates                                       ND
  Blood culture / organism                                                                                                                                                Negative                                                                  Enterococcus faecium                                                             Negative
  White blood cells on presentation- K/mm^3^                                                                                                                              4.4                                                                       15.5                                                                             11.5
  Hemoglobin- g/dl                                                                                                                                                        15.1                                                                      14.4                                                                             13.7
  Platelets- K/mm^3^                                                                                                                                                      199                                                                       246                                                                              266
  Creatine Kinase total- unit/L                                                                                                                                           ND                                                                        58                                                                               343
  Troponin- ng/ml                                                                                                                                                         ND                                                                        0.04                                                                             0.01
  Sodium- meq/L                                                                                                                                                           135                                                                       141                                                                              136
  Potassium- meq/L                                                                                                                                                        3.9                                                                       3.6                                                                              3.9
  Chloride- meq/L                                                                                                                                                         102                                                                       103                                                                              103
  HCO3- meq/L                                                                                                                                                             23                                                                        24                                                                               22
  BUN- mg/dl                                                                                                                                                              11                                                                        21                                                                               11
  Creatine- mg/dl                                                                                                                                                         1.23                                                                      0.65                                                                             0.75
  AST/ALT-U/L                                                                                                                                                             31/30                                                                     20/15                                                                            81/55
  ESR- mm/hr                                                                                                                                                              43                                                                        38                                                                               67
  CRP- mg/L                                                                                                                                                               45.8                                                                      144.5                                                                            203.2
  IL-6- pg/ml                                                                                                                                                             62.1                                                                      155.2                                                                            51
  Fibrinogen- mg/dl                                                                                                                                                       ND                                                                        546                                                                              ND
  Ferritin- ng/ml                                                                                                                                                         ND                                                                        270                                                                              76
  Treatment for COVID-19                                                                                                                                                  Hydroxychloroquine, azithromycin and ceftriaxone                          Hydroxychloroquine, azithromycin, ceftriaxone, tocilizumab convalescent plasma   Hydroxychloroquine, azithromycin ceftriaxone
  Treatment for influenza                                                                                                                                                 Oseltamivir                                                               Oseltamivir                                                                      Oseltamivir
  Intubation                                                                                                                                                              Yes                                                                       Yes                                                                              No
  Outcome                                                                                                                                                                 Discharged                                                                Discharged                                                                       Discharged
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------------------------- ----------------------------------------------

Discussion
==========

In a metanalysis study, 3% of patients hospitalized with COVID-19 were also co-infected with another respiratory virus; respiratory syncytial virus (RSV) and influenza A being the most common viral pathogens identified \[[@REF4]\]. Table [2](#TAB2){ref-type="table"} summarizes salient differences between the two viruses \[[@REF4]-[@REF7]\].

###### Summarizes salient differences between the two viruses.

  -------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                 Influenza                                                                                                                                                                                                                                                           COVID-19
  Virus characteristics                                          Influenza viruses are negative-sense single-strand RNA viruses with a segmented genome                                                                                                                                                                              Coronaviruses are positive-sense single-stranded, RNA viruses with an unsegmented, genome
  Incubation period                                              1 to 4 days (average 2 days)                                                                                                                                                                                                                                        Generally, within 14 days following exposure, with most cases occurring approximately four to five days after exposure
  Transmission                                                   Respiratory droplets and contact                                                                                                                                                                                                                                    Respiratory droplets and contact
  Diagnostic tests                                               Antigen detection assays reverse-transcription polymerase chain reaction (RT-PCR), multiplex PCR, and rapid molecular assays                                                                                                                                        Nucleic acid amplification testing (NAAT) most commonly with RT-PCR assay
  Chest X-ray                                                    Bilateral reticular or reticulonodular opacities with or without superimposed consolidation                                                                                                                                                                         Consolidation and ground glass opacities
  Signs and symptoms                                             Fever, headache, myalgia, malaise, cough, sore throat, and nasal discharge. Gastrointestinal illness, such as vomiting and diarrhea, is usually not part of influenza infections in adults but can occur in 10 to 20 percent of influenza infections in children.   Fever, cough, dyspnea, nasal discharge, myalgias. However, diarrhea and smell or taste disorders, are also common. Other manifestations include conjunctivitis and dermatologic manifestations - maculopapular, urticarial, and vesicular eruptions and transient livedo reticularis
  Laboratory abnormalities                                       Leukocyte counts are normal or low early in the illness but may become elevated later in the illness                                                                                                                                                                Lymphopenia, elevated aminotransaminase levels, elevated lactate dehydrogenase levels, elevated inflammatory markers (e.g., ferritin, C-reactive protein, and erythrocyte sedimentation rate), and abnormalities in coagulation tests.
  Treatment                                                      FDA-approved antiviral drugs                                                                                                                                                                                                                                        Optimal approach to treatment of COVID-19 is uncertain. Preliminary evidence suggests role for antiviral agent - remdesivir and dexamethasone in the management of COVID-19
  Vaccine                                                        FDA-licensed influenza vaccines produced annually                                                                                                                                                                                                                   Currently there is no vaccine to prevent COVID-19, clinical trials available
  Complications                                                  Acute respiratory distress syndrome (ARDS), myositis, rhabdomyolysis, acute myocardial infarction, myocarditis and pericarditis, toxic-shock syndrome, Guillain--Barre syndrome, transverse myelitis, encephalopathy                                                Acute respiratory distress syndrome (ARDS), myocarditis, heart failure, acute coronary syndrome, arrhythmias, cardiogenic shock, thromboembolic complications (pulmonary embolism, acute limb ischemia, mesenteric thrombosis, acute stroke), multisystem inflammatory syndrome and Guillain--Barre syndrome.
  Bacterial co-infection in intensive care unit (ICU) patients   More prevalent (19% of cases)                                                                                                                                                                                                                                       Less prevalent (14% of cases)
  Most commonly detected bacterial pathogen                      Streptococcus pneumoniae, Staphylococcus aureus, Streptococcus pyogenes                                                                                                                                                                                             Mycoplasma pneumoniae, Pseudomonas aeruginosa, Hemophilus influenzae, Klebsiella pneumoniae
  -------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Conclusions
===========

In conclusion, we report three cases of co-infection of influenza and COVID-19. Health care providers should be aware of this unique situation as both can present with similar symptoms but vary in treatment. Clinicians should have a high index of suspicion in the appropriate clinical scenario. Further studies are needed to determine whether patients who have a concurrent viral infection have a worse prognosis than those in whom SARS-CoV-2 is the only detected pathogen.
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